Hervé Berthomme

Title: Hervé Berthomme: Innovator in Nucleic Acid Analysis

Introduction

Hervé Berthomme is a notable inventor based in Bron, France. He has made significant contributions to the field of nucleic acid analysis, particularly through his innovative methods and technologies. His work has implications for genetic research and medical diagnostics.

Latest Patents

Hervé Berthomme holds 1 patent related to a method for analyzing nucleic acids. This invention utilizes a small-size probe array that comprises deoxyinostines (dI) instead of deoxyguanidines (dG). The patent details methods for detecting and quantifying target oligonucleotides present in DNA or RNA samples. It specifically addresses the mRNA editing rate of the serotonin 5-HT receptor (5-HT-R). The invention also includes biochips and reactors that utilize these probe arrays for identifying genetic polymorphisms and determining mRNA editing rates. Furthermore, it outlines methods for diagnosing diseases associated with mRNA editing and selecting compounds that can modulate this editing rate.

Career Highlights

Throughout his career, Hervé Berthomme has worked with various companies, including Biocortech and Marco Polo Pharmaceuticals. His experience in these organizations has contributed to his expertise in the field of biotechnology and pharmaceuticals.

Collaborations

Hervé has collaborated with notable individuals in his field, including Jean-Jacques Madjar. These collaborations have likely enriched his research and development efforts.

Conclusion

Hervé Berthomme's innovative work in nucleic acid analysis showcases his commitment to advancing genetic research and medical diagnostics. His contributions are significant in the ongoing exploration of genetic polymorphisms and mRNA editing.